Pharmacological SOS1 inhibitor BI-3406 demonstrates <i>in vivo</i> anti-tumor activity comparable to SOS1 genetic ablation in KRAS mutant tumors

Fernando C. Baltanás(Instituto de Biomedicina de Sevilla), Eugenio Santos(Universidad de Salamanca)

bioRxiv (Cold Spring Harbor Laboratory)

September 22, 2024

10.1101/2024.09.18.613686

Cited by 3

Related Papers

Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

|Nature Communications|2023|24

The CSN3 subunit of the COP9 signalosome interacts with the HD region of Sos1 regulating stability of this GEF protein

|Oncogenesis|2019|15

Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis

|Cancers|2021|14